Profound Medical Corp T.PRN

Alternate Symbol(s): PROF

Technology Scientific & Technical Instruments

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low -, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

TSX:PRN - Post by User

Profound Medical Corp

Bullboard Posts

Comment by BuenaSuertaAtodon Aug 30, 2019 10:44am

67 Views

Post# 30083120

RE:What happens if it gets through the 52-week high?

It IS through the 52-week high.

A lot of shares traded around and just above $1, up to something like $1.10. So I'd expect a slow march higher with some pull-backs before the move upward accelerates at about $1.10ish.

Bullboard Posts

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide